Summary
- Current Price
- As of today, NMRA price is $3.23, up +2.87% in the most recent trading session on
- Current Price All-Time High
- NMRA price is currently -84.62% below its historical high of $21.00 set on
- Market Cap
- NMRA current market cap is $549M, up +142.07% over the past 365 days
- PE Ratio
- NMRA PE ratio is unknown
- Revenue
- NMRA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for NMRA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Neumora Therapeutics, Inc. |
| Ticker | NASDAQ: NMRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | neumoratx.com |
| Employees | 103 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $3.23 | |
| Price, 1D Change | +2.87% | |
| $549M | ||
| - | ||
| - | ||
| 1.25 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.53 | ||
| EPS, 1Y Change | -2.98% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.53 | ||
| EPS Estimate | -$1.43 | |
| EPS Est. Change | +6.81% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $3.23 | |
| Price Target | - | $7.63 |
| Price Tgt. Change | - | +136.21% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.75 | -$1.49 | +15.12% | |
| -$1.60 | -$1.53 | +4.21% | |
| -$1.43 | N/A | +6.81% | |
| -$1.00 | N/A | +34.94% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $555.56K | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $3.23 | |
| $1.94 | ||
| SMA 200 vs Price | -39.84% | |
| $2.58 | ||
| SMA 50 vs Price | -20.09% | |
| 1.25 | ||
| $0.26 | ||
| 54.00 | ||
| 72.54% | ||
| 105.64% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.53 | ||
| -$631.00K | ||
| - | ||
| -$263.46M | ||
| - | ||
| -$243.79M | ||
| - | ||
| -$262.83M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 10.51 | ||
| 10.51 | ||
| - | ||
| - | ||
| 5.16 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 4.15 | ||
| -1.65 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $287.06M | ||
| $142.15M | ||
| $316.97M | ||
| $314.06M | ||
| $29.91M | ||
| $29.89M | ||
| $1.85M | ||
| $1.85M | ||
| $3.31M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $243.79M | ||
| $262.83M | ||
| $631.00K | ||
| $62.54M | ||
| $631.00K | ||
| $0.00 | ||
| $178.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$182.94M | ||
| -$70.56M | ||
| $21.60M | ||
| $0.00 | ||
| -$182.94M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| William Blair | → | |
| Leerink Partners | ||
| RBC Capital | → | |
| Stifel | → | |
| Needham | → | |
| Guggenheim | → | |
| JP Morgan | → | |
| Mizuho | → | |
| Needham | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with NMRA
FAQ
What is the ticker symbol for Neumora Therapeutics, Inc.?
The ticker symbol for Neumora Therapeutics, Inc. is NASDAQ:NMRA
Does Neumora Therapeutics, Inc. pay dividends?
No, Neumora Therapeutics, Inc. does not pay dividends
What sector is Neumora Therapeutics, Inc. in?
Neumora Therapeutics, Inc. is in the Healthcare sector
What industry is Neumora Therapeutics, Inc. in?
Neumora Therapeutics, Inc. is in the Biotechnology industry
What country is Neumora Therapeutics, Inc. based in?
Neumora Therapeutics, Inc. is headquartered in United States
When did Neumora Therapeutics, Inc. go public?
Neumora Therapeutics, Inc. initial public offering (IPO) was on September 15, 2023
Is Neumora Therapeutics, Inc. in the S&P 500?
No, Neumora Therapeutics, Inc. is not included in the S&P 500 index
Is Neumora Therapeutics, Inc. in the NASDAQ 100?
No, Neumora Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Neumora Therapeutics, Inc. in the Dow Jones?
No, Neumora Therapeutics, Inc. is not included in the Dow Jones index
When was Neumora Therapeutics, Inc. last earnings report?
Neumora Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Neumora Therapeutics, Inc. report earnings?
The next expected earnings date for Neumora Therapeutics, Inc. is March 13, 2026
Data Sources & References
- NMRA Official Website www.neumoratx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1885522/000119312525269446/0001193125-25-269446-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1885522/000095017025030401/0000950170-25-030401-index.htm
- NMRA Profile on Yahoo Finance finance.yahoo.com/quote/NMRA
- NMRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nmra